Floatz logo

Therapeutic Asset Ratings

9,919 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Rosuvastatin
Sickle Cell Disease
PfizerP1CC (43)
Rph-075
Squamous Cell Lung Carcinoma
R-PharmP1CC (43)
Rqnestin
Anaplastic Oligodendroglioma
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Astrocytic Tumor
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Ependymoma
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Ganglioglioma
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Anaplastic Astrocytoma
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Brain Glioma
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Oligoastrocytoma
Dana-Farber Cancer InstituteP1CC (43)
Rqnestin
Pilocytic Astrocytoma
Dana-Farber Cancer InstituteP1CC (43)
rs001
B-Cell Non-Hodgkin Lymphoma
Guangdong Ruishun Biotech Co., LtdP1CC (43)
R-Tm123
Acute Myeloid Leukemia
AvenCell Therapeutics, Inc.P1CC (43)
Ruserontinib
Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P1CC (43)
Ruxolitinib
Childhood Acute Lymphoblastic Leukemia
University of ChicagoP1CC (43)
Ruxolitinib
B-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (43)
Ruxolitinib
Histiocytic And Dendritic Cell Neoplasm
Mayo ClinicP1CC (43)
Ruxolitinib
Pancreatic Adenocarcinoma
Philogen S.p.A.P1CC (43)
Ruxolitinib
Neoplasm Of Mature T-Cells Or NK-Cells
Memorial Sloan Kettering Cancer CenterP1CC (43)
Ruxolitinib
Angioimmunoblastic T-Cell Lymphoma
Mayo ClinicP1CC (43)
Ruxolitinib
T-Cell Large Granular Lymphocyte Leukemia
Memorial Sloan Kettering Cancer CenterP1CC (43)
Ruxolitinib Phosphate
Angioimmunoblastic T-Cell Lymphoma
City of Hope Medical CenterP1CC (43)
Ruxolitinib Phosphate
Peripheral T-Cell Lymphoma, Not Otherwise Specified
City of Hope Medical CenterP1CC (43)
Rybelsus
Prediabetes Syndrome
The University of Texas Health Science Center at San AntonioP1CC (43)
ryz101
Small Cell Lung Carcinoma
RayzeBio, Inc.P1CC (43)
ryz401
Carcinoid Tumor
RayzeBio, Inc.P1CC (43)
Showing 4101 to 4125 of 9,919 assets
PreviousPage 165 of 397Next